Cancer treatment induced metabolic syndrome: Improving outcome with lifestyle.

Westerink, N L; Nuver, J; Lefrandt, J D; Vrieling, A H; Gietema, J A; Walenkamp, A M E

Westerink, N L; Nuver, J; Lefrandt, J D; Vrieling, A H; Gietema, J A; Walenkamp, A M E.

Afiliação

Westerink NL; Department of Medical Oncology, University of Groningen, University Medical Centre Groningen, Hanzeplein 1, 9713 GZ Groningen, The Netherlands.
Nuver J; Department of Medical Oncology, University of Groningen, University Medical Centre Groningen, Hanzeplein 1, 9713 GZ Groningen, The Netherlands.
Lefrandt JD; Department of Vascular Medicine, University of Groningen, University Medical Centre Groningen, Hanzeplein 1, 9713 GZ Groningen, The Netherlands.
Vrieling AH; Department of Rehabilitation Medicine, University of Groningen, University Medical Centre Groningen, Hanzeplein 1, 9713 GZ Groningen, The Netherlands.
Gietema JA; Department of Medical Oncology, University of Groningen, University Medical Centre Groningen, Hanzeplein 1, 9713 GZ Groningen, The Netherlands.
Walenkamp AM; Department of Medical Oncology, University of Groningen, University Medical Centre Groningen, Hanzeplein 1, 9713 GZ Groningen, The Netherlands. Electronic address: a.walenkamp@umcg.nl.

Crit Rev Oncol Hematol ; 108: 128-136, 2016 Dec.

Article em En | MEDLINE | ID: mdl-27931830

Assuntos

Síndrome Metabólica/etiologia; Neoplasias/terapia; Animais; Humanos; Estilo de Vida; Síndrome Metabólica/epidemiologia; Prevalência; Resultado do Tratamento

Palavras-chave

Cancer; Cancer treatment protocols; Exercise; Life style; Metabolic syndrome X; Survivors

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Síndrome Metabólica / Neoplasias Idioma: En Ano de publicação: 2016 Tipo de documento: Article País de afiliação: Holanda

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google